SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

Discover key insights from Enphase Energy's Q1 2025 earnings call, including revenue performance, tariff strategies, and product innovation driving ...

Tesla's earnings report missed estimates, with revenue down 9%. Read a recap of the analyst call, where Elon Musk talked ...

Investors should consider reform-independent companies with strong balance sheets or those with clear growth catalysts, like ...

New York City Deputy Mayor Adolfo Carrion Jr., the New York City Economic Development Corporation (NYCEDC), and Con Agg Global (CAG) announced a new waterside transloading facility to be located ...

Roth Capital analyst Rohit Kulkarni lowered the firm’s price target on Meta Platforms (META) to $580 from $730 and keeps a Buy rating on the ...

GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore's premier biotech ...

In a report released today, Rohit Kulkarni from Roth MKM maintained a Buy rating on Meta Platforms (META – Research Report), with a price ...

Understanding the allocations in your Roth IRA can help manage volatility and set realistic expectations for long-term ...

Film stars might seem to be making some inroads with this year’s New York Drama League Awards nominations – George Clooney, ...

More than 200 college presidents and other officials signed a letter Tuesday protesting the “unprecedented government ...

Robert Schwartz joined Morgan Lewis as a partner in its investment management practice in Washington, the firm announced ...